teaser
The previously announced $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital was completed today.
The company’s many well-known brands, established in more than 30 years of leadership in the healthcare industry, include Advantage Suite®, Action OI®, MarketScan®, 100 Top Hospitals®, CareDiscoveryTM and Micromedex®.
The newly independent company will be known as Truven Health Analytics, a name based on the words ‘truth’ and ‘proven’ that speaks to the strength of its offerings, expertise, and people.
“Truven Health Analytics is the industry’s leading provider of trusted and unbiased healthcare information, analytic tools and benchmarks,” said Robert McKeon, chairman of Veritas Capital.
“Their solutions sit at the centre of virtually every major healthcare challenge currently confronting hospitals, employers, federal and state governments, pharmaceutical companies and health plans.
“We look forward to working with the management team and employees to build upon the strong foundation in place to continue delivering value to our customers.”
Truven Health Analytics provides data, analytics and performance benchmarking solutions and services to hospitals, health systems, employers, health plans, government agencies and pharmaceutical companies.
With leading assets and solutions coupled with expert services and analysis, Truven Health Analytics provides its customers with solutions to identify savings, improve outcomes, detect fraud and more efficiently manage their healthcare operations.
Truven Health Analytics is uniquely positioned to address the industry’s convergent healthcare trends, including the increased use of benchmarks to assess quality care, implementation of health information exchanges and other electronic data initiatives spurred by healthcare reform, more rigorous investigations of healthcare waste and abuse, and the development of population health programs among hospitals, health plans, and large employers.
“The healthcare industry is constantly striving for higher quality and improved efficiency, and our new partnership with Veritas Capital will help us harness the power of our world class team to tackle some of the industry’s biggest challenges,” said Mike Boswood, President and CEO of Truven Health Analytics.
“We’re eager to realise the potential that our future holds.”
Truven Health Analytics
